| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,038 |
4,962 |
$707K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,856 |
4,669 |
$501K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,942 |
4,891 |
$468K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,008 |
4,547 |
$363K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,968 |
5,466 |
$239K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,350 |
1,656 |
$47K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,092 |
2,013 |
$42K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,208 |
2,169 |
$35K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
161 |
157 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
63 |
62 |
$4K |
| 81002 |
|
1,160 |
1,120 |
$4K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
274 |
272 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
447 |
435 |
$758.73 |
| 86769 |
|
12 |
12 |
$487.52 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
58 |
58 |
$351.67 |
| 87807 |
|
20 |
20 |
$317.64 |
| 99000 |
|
4,534 |
4,161 |
$219.50 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
284 |
277 |
$187.06 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
36 |
33 |
$29.62 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$16.13 |